Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.
about
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic VirusesImmune modulation of the tumor microenvironment for enhancing cancer immunotherapyEvaluation of the safety and biodistribution of M032, an attenuated herpes simplex virus type 1 expressing hIL-12, after intracerebral administration to aotus nonhuman primates.Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic virusesMesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice.Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1Oncolytic tanapoxvirus expressing FliC causes regression of human colorectal cancer xenografts in nude mice.Chemokines, costimulatory molecules and fusion proteins for the immunotherapy of solid tumors.Bevacizumab with angiostatin-armed oHSV increases antiangiogenesis and decreases bevacizumab-induced invasion in U87 glioma.Genetic strategies for brain tumor therapy.Preclinical evaluation of oncolytic δγ(1)34.5 herpes simplex virus expressing interleukin-12 for therapy of breast cancer brain metastasesCombination of oncolytic herpes simplex viruses armed with angiostatin and IL-12 enhances antitumor efficacy in human glioblastoma models.Oncolytic herpes viruses, chemotherapeutics, and other cancer drugsDesign of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Patients with Recurrent/Progressive Glioblastoma Multiforme, Anaplastic Astrocytoma, or Gliosarcoma.Strategies for the rapid construction of conditionally-replicating HSV-1 vectors expressing foreign genes as anticancer therapeutic agents.Chemokine-based immunotherapy: delivery systems and combination therapies.Oncolytic Immunotherapy for Treatment of Cancer.T-independent response mediated by oncolytic tanapoxvirus recombinants expressing interleukin-2 and monocyte chemoattractant protein-1 suppresses human triple negative breast tumors."Armed" oncolytic herpes simplex viruses for brain tumor therapy.Engineered herpes simplex virus expressing bacterial cytosine deaminase for experimental therapy of brain tumors.New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy.Gene therapy and targeted toxins for glioma
P2860
Q26767212-A113806E-BA58-4353-BE36-E38ED98B70CCQ27002646-4FF92A8F-9CFB-4847-A1AC-FC3C9A83224EQ33720628-F2A9A280-04D8-489C-A94A-E55311B1B71AQ33773376-50C06097-2CA1-4733-B1C9-32C68D70397DQ34119602-BB390F88-724A-4FDD-8E1F-A3210A304A72Q35060701-0B5161CF-425B-4DE9-8205-B779656C7038Q35110264-C11641CF-DE3A-44F1-B593-63A0B64C9079Q35580479-6ED573C0-AE7D-4E66-80CA-8745F72CDAFBQ35665220-308BEA2C-4D91-413F-AAB2-338850206555Q36247099-9655671C-5F1F-495B-836F-019BE2D2340AQ36546412-D7B02FB7-DB6D-4473-BBE4-A96525B2FDD3Q36879211-45340701-2DB4-44B3-BA55-35B188CD0793Q37031896-4C3CF98A-02B5-4D26-93D5-3C3FC6213AAFQ37064326-3462A045-6BB1-4C05-9AA2-EBC72F1D32B8Q37818121-E1B50998-EE66-4CF3-AC2D-F06D68053788Q38040509-3C42FE77-128C-42CD-BB1E-B33C91AB84D5Q38848223-468F0D4C-D7C0-4249-AFAB-CAED8D083AE8Q39499897-F19686C2-5CF2-4564-87B3-B2B30C4479EBQ43189897-8C08A9A5-9B7D-46D3-BB70-953A7D893A5DQ45411954-0F91ECF0-BEFF-4FBF-BE17-A49523D89CA1Q50056861-5AE0F027-9385-4E8F-9BF8-40C01D0DF516Q57006162-4F4186D3-D032-4F1F-89C1-F4F77B72E8A0
P2860
Enhanced inhibition of syngeneic murine tumors by combinatorial therapy with genetically engineered HSV-1 expressing CCL2 and IL-12.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Enhanced inhibition of syngene ...... V-1 expressing CCL2 and IL-12.
@en
type
label
Enhanced inhibition of syngene ...... V-1 expressing CCL2 and IL-12.
@en
prefLabel
Enhanced inhibition of syngene ...... V-1 expressing CCL2 and IL-12.
@en
P2093
P2860
P356
P1433
P1476
Enhanced inhibition of syngene ...... V-1 expressing CCL2 and IL-12.
@en
P2093
G Yancey Gillespie
Jacqueline N Parker
James M Markert
Kenneth B Hughes
Richard J Whitley
Sreelatha Meleth
P2860
P2888
P304
P356
10.1038/SJ.CGT.7700784
P577
2005-04-01T00:00:00Z
P5875
P6179
1053722647